Director, Medical Affairs, GI, Japan

Job description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

We are seeking a highly motivated and experienced professional to join our team as a Director, Medical Affairs for gastrointestinal cancers (GI). This role will oversee the development and execution of medical strategies and tactics in Japan, including evidence generation, publications, and congress activities. In addition, the Director will manage the MSL team for GI to engage in peer-to-peer scientific dialogue with healthcare professionals that translate into meaningful insights; serve as a therapeutic expert and thought partner to internal teams; act as a liaison between Revolution Medicines and clinical study sites/investigators; and organize medical education programs, advisory boards, and medical congress activities.

Reporting to the Head of Japan Medical Affairs, Director, Medical Affairs, GI is an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. They will serve as a key strategic and field person between Revolution Medicines and healthcare professionals in collaboration with the Medical Leads and the MSL team. Within assigned geographic territory, this individual will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and highly collaborative.

Key Responsibilities:

•
Develops and executes the Japan medical strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy.

•
Develops and executes a Health Care Professional (HCP) engagement strategy to gather insights to shape internal programs.

•
Acts as the medical representative on cross-functional teams.

•
Serves as a therapeutic area content expert.

•
Supports the execution of routine gap assessments leading to the development/refinement of publication strategy, evidence generation plans, and tactical plan as part of the overall medical

•
Provides medical leadership in scientific engagement activities with key external stakeholders by organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions, and communicates the resulting of scientific insights to internal teams to drive strategy.

•
Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programs, and scientific discussions.

•
Represents various medical affairs functions in cross-functional strategy team meetings including Clinical and Safety sub-teams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other cross-functional strategic discussions.

•
Works with the Clinical and MSL team to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines.

•
Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the GMA Plan.

•
Works with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants, respectively.

•
Provides medical support for scientific symposia and medical congresses and collaborates across Medical Affairs functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines.

•
Supports the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data.

•
Collaborates with stakeholders across the organization, inc

Prepare for the interview

Nothing collected for this employer yet. The Blind 75 is what technical screens draw from; practice it here, with a coach, in Java or Python.

More at Revolution Medicines

• Associate Director, Healthcare Law · Remote (United States)
• Associate Director, Intellectual Property · Redwood City, California, United States
• Associate Director, Launch Excellence · Remote (United States)
• Associate Director, Medical Information, Europe · Basel, Switzerland; Paris, France
• Associate Director, Medical Lead, GI, Japan · Tokyo, Japan
• Associate Director, Medical Lead, Lung, Japan · Tokyo, Japan
• Director, Commercial Project Management · Remote (United States)
• Director, Marketing, Europe · Milan, Italy